carbamazepine has been researched along with Neurally Mediated Faint in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellenbogen, KA | 1 |
| Wood, MA | 1 |
| Kontos, HA | 1 |
1 other study available for carbamazepine and Neurally Mediated Faint
| Article | Year |
|---|---|
Management of refractory neurocardiogenic syncope.
Topics: Adult; Carbamazepine; Humans; Male; Middle Aged; Phenytoin; Recurrence; Syncope, Vasovagal | 1998 |